Search results

Filter

Filetype

Your search for "what do you do on the dark web 【Visit Sig8.com】9ZP42K8.5R9I" yielded 91265 hits

Alzheimer’s awareness: Five research projects shaping the future of understanding, diagnosis and care

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-05-13

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-05-13

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.multipark.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-13

Dedicated alumna launched Minnesota model in Sweden

This article is over 5 years old, and the information may therefore be outdated. “Education and knowledge are the way to change society for the better. I want to make a difference and help to give young people the same fantastic opportunities I had”, says alumna Monica Getz Silfverschöld, a new board member for the Lund University Foundation (LUF). LUF is an independent foundation that aims to str

https://www.staff.lu.se/article/dedicated-alumna-launched-minnesota-model-sweden - 2026-05-13

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.medicine.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-05-13

Psychedelics in the treatment of anorexia – a new pilot study

Anorexia nervosa is a serious psychiatric disorder for which there are limited treatment options, and it has one of the highest mortality rates of any psychiatric diagnosis. A pilot study is now underway at Lund University in Sweden, where researchers are investigating whether psychedelic drugs have an effect on young patients with the disorder. Ward Five at the adult psychiatric clinic in Lund is

https://www.medicine.lu.se/article/psychedelics-treatment-anorexia-new-pilot-study - 2026-05-13

Precision medicine research within type 2 diabetes and dementia receives support

Three research groups at Lund University Diabetes Centre receive new project grants within precision medicine. The aim with the projects is to develop individualised treatment strategies that may benefit people with type 2 diabetes. One of the new projects will investigate whether it is possible to develop individualised treatment strategies for people with type 2 diabetes. The project EPIPREDIA i

https://www.medicine.lu.se/article/precision-medicine-research-within-type-2-diabetes-and-dementia-receives-support - 2026-05-13

Universal method could transform the future of bone transplantation

Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely guide bone repair without triggering strong immune responses. The transplant has been successfully tested in animal models, and the next step is to evaluate the tissue engineering approach in humans.

https://www.medicine.lu.se/article/universal-method-could-transform-future-bone-transplantation - 2026-05-13

New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.medicine.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-13

Lund University professor to lead Nature Medicine Commission on Data-driven Obesity Management

The Nature Medicine Commission on Data-Driven Obesity Management will bring together global experts and datasets to tackle the growing burden of obesity-related noncommunicable diseases through data-driven decision support. “Our goal is to generate evidence that supports better and more equitable care for people living with obesity worldwide,” says the Commission Chair and Professor Paul Franks at

https://www.medicine.lu.se/article/lund-university-professor-lead-nature-medicine-commission-data-driven-obesity-management - 2026-05-13

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies. The team has taken an important step toward harnessing the immune system to fight cancer. Their work describes how

https://www.stemcellcenter.lu.se/article/scientists-uncover-cellular-toolkit-reprogram-immune-cells-cancer-therapy - 2026-05-13

Update on STEM-PD clinical trial – stem cell-based transplant for Parkinson’s disease

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.stemcellcenter.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-05-13

The Nile – lifeblood and source of conflict

This article is over 5 years old, and the information may therefore be outdated. The construction of a dam in Ethiopia could solve many problems for the growing population along the Nile. However, when the construction of the Grand Ethiopian Renaissance Dam began, it was met with warmongering from countries downstream. Egypt in particular felt threatened by the dam, which would regulate the Nile,

https://www.staff.lu.se/article/nile-lifeblood-and-source-conflict - 2026-05-13

Universal method could transform the future of bone transplantation

Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely guide bone repair without triggering strong immune responses. The transplant has been successfully tested in animal models, and the next step is to evaluate the tissue engineering approach in humans.

https://www.stemcellcenter.lu.se/article/universal-method-could-transform-future-bone-transplantation - 2026-05-13

Hindrik Mulder is the incoming editor-in-chief of Diabetologia

This article is over 5 years old, and the information may therefore be outdated. Research published in the research journal Diabetologia needs to meet a high standard of quality. Most of the manuscripts submitted are rejected. At the start of 2021, Hindrik Mulder, MD and professor at Lund University Diabetes Centre (LUDC), will take over as editor-in-chief of the journal. After just over 10 years

https://www.medicine.lu.se/article/hindrik-mulder-incoming-editor-chief-diabetologia - 2026-05-13

Daniella Rylander Ottosson named as Wallenberg Academy Fellow

Using methods for reprogramming human glia cells top create specialised nerve cells, interneurons, researcher Daniella Rylander Ottosson aims to lay the foundations for future treatments of diseases such as schizophrenia and epilepsy. Of the 27 new Wallenberg Academy Fellows, two are at Lund University: Daniella Rylander Ottosson, who is conducting research into regenerative neurophysiology at the

https://www.medicine.lu.se/article/daniella-rylander-ottosson-named-wallenberg-academy-fellow - 2026-05-13

Historia: Diabetes - en underlig sjukdom

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. Världsdiabetesdagen firas den 14 november, Frederick Bantings födelsedag. Han har fått äran av att 1921 ha upptäckt insulinet. För nästan 2000 år sedan gav den turkiske läkaren Aretaios sjukdomen sitt namn. ”Det syns mig som om sjukdomen bör kallas diabetes – något som liknar ett vattenrör, därför att vätskan inte s

https://www.diabetesportalen.lu.se/artikel/historia-diabetes-en-underlig-sjukdom - 2026-05-13

Ny studie: Alzheimers sjukdom – fyra distinkta subtyper

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. Alzheimers sjukdom kännetecknas av onormal spridning och ansamling av proteinet tau i hjärnan. En internationell studie visar nu hur tau sprids enligt fyra distinkta mönster som leder till olika symtom med olika prognoser för de drabbade individerna. Studien publiceras i Nature Medicine. – Till skillnad mot hur vi h

https://www.medicin.lu.se/artikel/ny-studie-alzheimers-sjukdom-fyra-distinkta-subtyper - 2026-05-13

Ny studie: Alzheimers sjukdom – fyra distinkta subtyper

Alzheimers sjukdom kännetecknas av onormal spridning och ansamling av proteinet tau i hjärnan. En internationell studie visar nu hur tau sprids enligt fyra distinkta mönster som leder till olika symtom med olika prognoser för de drabbade individerna. Studien publiceras i Nature Medicine. – Till skillnad mot hur vi hittills tolkat spridningen av tau i hjärnan, visar fynden från denna studie att tau

https://www.lu.se/artikel/ny-studie-alzheimers-sjukdom-fyra-distinkta-subtyper - 2026-05-14